Sumitomo Dainippon Pharma Co Ltd (DNPUF)
OTHER OTC:DNPUF
Holding DNPUF?
Track your performance easily

Sumitomo Dainippon Pharma Co (DNPUF) Financial Statements

7 Followers

Sumitomo Dainippon Pharma Co Financial Overview

Sumitomo Dainippon Pharma Co's market cap is currently ―. The company's EPS TTM is $-4.439; its P/E ratio is -1.04; Sumitomo Dainippon Pharma Co is scheduled to report earnings on October 28, 2024, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue¥ 140.98B-¥ 159.88B¥ 127.96B¥ 138.34B
Gross Profit¥ 94.05B-¥ 113.82B¥ 88.67B¥ 97.36B
EBIT¥ 11.14B-¥ 47.49B¥ 18.14B¥ 17.09B
EBITDA¥ 20.86B-¥ 59.01B¥ 28.30B¥ 27.18B
Net Income Common Stockholders¥ -11.22B-¥ 31.11B¥ 10.05B¥ 9.91B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 288.26B¥ 0.00¥ 265.59B¥ 238.58B¥ 208.08B
Total Assets¥ 1.37T-¥ 1.42T¥ 1.31T¥ 1.30T
Total Debt¥ 249.71B¥ 0.00¥ 268.91B¥ 269.05B¥ 269.75B
Net Debt¥ -38.55B¥ 0.00¥ 3.32B¥ 30.47B¥ 61.67B
Total Liabilities--¥ 678.52B¥ 634.44B¥ 630.14B
Stockholders Equity¥ 635.15B¥ 0.00¥ 673.01B¥ 607.89B¥ 600.79B
Cash Flow-
Free Cash Flow¥ 23.13B-¥ 9.23B¥ 19.38B¥ 34.18B
Operating Cash Flow¥ 27.05B-¥ 13.19B¥ 22.18B¥ 37.27B
Investing Cash Flow¥ 14.62B-¥ 22.45B¥ -25.54B¥ 3.63B
Financing Cash Flow¥ -6.37B-¥ -6.64B¥ -1.03B¥ -7.15B
Currency in JPY

Sumitomo Dainippon Pharma Co Earnings and Revenue History

Sumitomo Dainippon Pharma Co Debt to Assets

Sumitomo Dainippon Pharma Co Cash Flow

Sumitomo Dainippon Pharma Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis